It is hypothesized that Ipamorelin potentially increased the weights of fat pads in relation to body weight, which appeared to lead to an increase in relative body fat as quantified by dual energy X-ray absorptiometry (DEXA)
Besson A, Salemi S, Gallati S, Jenal A, Horn R, Mullis PS, et al
AOD-9604 Trial Data (Efficacy, Adverse Events) AOD-9604 was studied across six randomized, double-blind, placebo-controlled trials involving roughly 900 participants between 2001 and 2006, making it one of the more extensively studied peptide fragments in human research
Research indicates that women may experience a higher incidence of gastrointestinal side effects compared to men, making it essential for them to approach these treatments with caution